Showing results (1-10 of 207) with videos related to
Sort By:
Pageof 21
Future Microbiology|February 18, 2015
The future for early-stage tuberculosis drug discoveryEdison S Zuniga, Julie Early, Tanya ParishAntimicrobial Agents and Chemotherapy|October 17, 2018
Activation of 2,4-Diaminoquinazoline in Mycobacterium tuberculosis by Rv3161c, a Putative DioxygenaseEduard Melief, Shilah A Bonnett, Edison S Zuniga, et al.Frontiers in Microbiology|November 13, 2018
Identification of Enolase as the Target of 2-Aminothiazoles in Mycobacterium tuberculosisHeather H Wescott, Edison S Zuniga, Anumita Bajpai, et al.Medchemcomm|July 16, 2019
Anthranilic amide and imidazobenzothiadiazole compounds disrupt Mycobacterium tuberculosis membrane potentialJake Smith, Heather Wescott, Julie Early, et al.Expert Opinion on Drug Discovery|January 5, 2020
In vitro drug discovery models for Mycobacterium tuberculosis relevant for host infectionTanya ParishChemistry & Biology|April 29, 2014
Targeting mycobacterial proteolytic complexes with natural productsTanya ParishJournal of Bacteriology|November 5, 2003
Starvation survival response of Mycobacterium tuberculosisTanya ParishMethods in Molecular Biology (Clifton, N.J.)|July 8, 2021
Electroporation of MycobacteriaTanya ParishBioorganic & Medicinal Chemistry|June 4, 2017
The synthesis and evaluation of triazolopyrimidines as anti-tubercular agentsEdison S Zuniga, Aaron Korkegian, Steven Mullen, et al.Pageof 21